PMID: 9554119Apr 29, 1998Paper

Specific immunotherapy of respiratory allergies

Bulletin de l'Académie nationale de médecine
J BousquetF B Michel

Abstract

Specific immunotherapy has been in routine use since 1911 for the treatment of respiratory allergic diseases. There is however a certain amount of controversies regarding its overall indications. Its efficacy has been demonstrated in double-blind placebo controlled studies in both allergic rhinoconjunctivitis and allergic asthma. The improvement of allergenic extracts (in particular by standardization), the better understanding of the mechanisms of action of immunotherapy, the recently proposed use of other administration routes and the publication of guidelines have legitimated its definite role to play in the therapeutic management of allergic respiratory diseases.

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Allergies & Environmental Factors

Environmental factors are strongly associated with the prevalence of allergies and are an increasing health concern worldwide. Discover the latest research on Allergies and Environmental Factors here.

Related Papers

Allergie et immunologie
Pascal DemolyJ Bousquet
Bulletin de l'Académie nationale de médecine
Pascal Demoly, François-Bernard Michel
© 2022 Meta ULC. All rights reserved